Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 25;15(17):3737.
doi: 10.3390/nu15173737.

Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment

Carla Micaela Cuttica  1 , Irene Maria Briata  2 , Andrea DeCensi  2   3
Affiliations
Review

Novel Treatments for Obesity: Implications for Cancer Prevention and Treatment

Carla Micaela Cuttica et al. Nutrients. .

Abstract

It is now established that obesity is related to a higher incidence of cancer during a lifespan. The effective treatment of obesity opens up new perspectives in the treatment of a relevant modifiable cancer risk factor. The present narrative review summarizes the correlations between weight loss in obesity and cancer. The current knowledge between obesity treatment and cancer was explored, highlighting the greatest potential for its use in the treatment of cancer in the clinical setting. Evidence for the effects of obesity therapy on proliferation, apoptosis, and response to chemotherapy is summarized. While more studies, including large, long-term clinical trials, are needed to adequately evaluate the relationship and durability between anti-obesity treatment and cancer, collaboration between oncologists and obesity treatment experts is increasingly important.

Keywords: anti-obesity agents; glucagon-like peptide 1; liraglutide; neoplasms; obesity; weight loss.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Global Obesity Observator Obesity Atlas 2022. [(accessed on 27 February 2023)]. Available online: https://data.worldobesity.org/publications/?cat=15.
    1. Bray G.A., Kim K.K., Wilding J.P.H. Obesity: A chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes. Rev. 2017;18:715–723. doi: 10.1111/obr.12551. - DOI - PubMed
    1. WHO European Regional Obesity Report 2022. [(accessed on 27 February 2023)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/353747/9789289057738-en....
    1. Lauby-Secretan B., Scoccianti C., Loomis D., Grosse Y., Bianchini F., Straif K. Body fatness and cancer—Viewpoint of the IARC Working Group. N. Engl. J Med. 2016;375:794–798. doi: 10.1056/NEJMsr1606602. - DOI - PMC - PubMed
    1. Furer A., Afek A., Sommer A., Keinan-Boker L., Derazne E., Levi Z., Tzur D., Tiosano S., Shina A., Glick Y., et al. Adolescent obesity and midlife cancer risk: A population-based cohort study of 2·3million adolescents in Israel. Lancet Diabetes Endocrinol. 2020;8:216–225. doi: 10.1016/S2213-8587(20)30019-X. - DOI - PubMed

Grants and funding

This research received no external funding.